Ads
related to: porphyria cutanea tarda nhs- AHP Disease Information
Review information about acute
hepatic porphyria and its effects.
- Treatment for AHP
Review an FDA-approved treatment
for your adult patients with AHP.
- Access & Support Services
Learn how to get your patients
started on a treatment for AHP.
- Dosing & Administration
Review dosing and administration
for an AHP treatment option.
- Clinical Study Data
See clinical study results on a
treatment for adults with AHP.
- Patient Experiences
Review patient experience
with AHP therapy.
- AHP Disease Information
Search results
Results From The WOW.Com Content Network
Porphyria cutanea tarda is the most common subtype of porphyria. [1] The disease is named because it is a porphyria that often presents with skin manifestations later in life. The disorder results from low levels of the enzyme responsible for the fifth step in heme production. Heme is a vital molecule for all of the body's organs.
Porphyria Cutanea Tarda (PCT): PCT is the most common form of porphyria, with an estimated prevalence of 1 to 2 cases per 10,000 individuals in the general population. It predominantly affects adults, with a higher prevalence in men than in women.
Acute intermittent porphyria (AIP) is a rare metabolic disorder affecting the production of heme resulting from a deficiency of the enzyme porphobilinogen deaminase. It is the most common of the acute porphyrias .
Porphyria cutanea tarda; V. Variegate porphyria; W. Watson–Schwartz test This page was last edited on 27 November 2020, at 02:14 (UTC). Text is available under ...
Erythropoietic protoporphyria (or commonly called EPP) is a form of porphyria, which varies in severity and can be very painful. It arises from a deficiency in the enzyme ferrochelatase , leading to abnormally high levels of protoporphyrin in the red blood cells (erythrocytes) , plasma, skin, and liver . [ 2 ]
The Watson–Schwartz test is a screening test for diagnosing intermittent porphyria, although it might also become positive in porphyria cutanea tarda (a skin form of porphyria). In this method, porphobilinogen is detected by a color reaction with Ehrlich reagent and confirming that the color is not removed by chloroform.
Ads
related to: porphyria cutanea tarda nhs